(Q82892503)

English

Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection

scientific article published on 01 December 2011

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

22157884

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157884%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

title

Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

22157884

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157884%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

main subject

isoniazid

0 references

Mycobacterium tuberculosis

1 reference

based on heuristic

inferred from title

author

Centers for Disease Control and Prevention

series ordinal

1

object named as

Centers for Disease Control and Prevention (CDC)

1 reference

stated in

Europe PubMed Central

PubMed ID

22157884

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157884%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

publication date

1 December 2011

1 reference

stated in

Europe PubMed Central

PubMed ID

22157884

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157884%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

Morbidity and Mortality Weekly Report

1 reference

stated in

Europe PubMed Central

PubMed ID

22157884

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157884%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

volume

60

1 reference

stated in

Europe PubMed Central

PubMed ID

22157884

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157884%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

issue

48

1 reference

stated in

Europe PubMed Central

PubMed ID

22157884

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157884%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

page(s)

1650-1653

1 reference

stated in

Europe PubMed Central

PubMed ID

22157884

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157884%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

Identifiers

PubMed ID

22157884

1 reference

stated in

Europe PubMed Central

PubMed ID

22157884

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22157884%20AND%20SRC:MED&resulttype=core&format=json

(Q82892503)

Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)